Kadimastem (XTAE:KDST) YoY EBITDA Growth : 63.27% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Kadimastem YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kadimastem's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 63.27%.

Kadimastem's EBITDA per Share for the six months ended in Dec. 2023 was ₪-0.97.

Kadimastem YoY EBITDA Growth Historical Data

The historical data trend for Kadimastem's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem YoY EBITDA Growth Chart

Kadimastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

36.09

43.11

21.74

42.47

61.67

Kadimastem Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial														26.84	45.50	41.02	60.10	63.27

Kadimastem YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kadimastem's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-2.246	-	-5.859)	/	\| -5.859 \|
=	61.67 %

Kadimastem's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.972	-	-2.646)	/	\| -2.646 \|
=	63.27 %

Kadimastem YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kadimastem's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadimastem (XTAE:KDST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

KMSTF:USA

Address

Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR

Website

http://www.kadimastem.com

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines